Works by Boertien, Wendy E

Results: 8

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).

Published in:

2013

By:

Riphagen, Ineke J;
Boertien, Wendy E;
Alkhalaf, Alaa;
Kleefstra, Nanne;
Gansevoort, Ron T;
Groenier, Klaas H;
van Hateren, Kornelis J J;
Struck, Joachim;
Navis, Gerjan;
Bilo, Henk J G;
Bakker, Stephan J L

Publication type:

journal article

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31).

Published in:

Diabetes Care, 2013, v. 36, n. 10, p. 3201, doi. 10.2337/dc12-2165

By:

RIPHAGEN, INEKE J.;
BOERTIEN, WENDY E.;
ALKHALAF, ALAA;
KLEEFSTRA, NANNE;
GANSEVOORT, RON T.;
GROENIER, KLAAS H.;
VAN HATEREN, KORNELIS J. J.;
STRUCK, JOACHIM;
NAVIS, GERJAN;
BILO, HENK J. G.;
BAKKER, STEPHAN J. L.

Publication type:

Article

Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.

Published in:

Nephrology Dialysis Transplantation, 2012, v. 27, n. 11, p. 4131, doi. 10.1093/ndt/gfs070

By:

Boertien, Wendy E.;
Meijer, Esther;
Zittema, Debbie;
van Dijk, Marjan A.;
Rabelink, Ton J.;
Breuning, Martijn H.;
Struck, Joachim;
Bakker, Stephan J.L.;
Peters, Dorien J.M.;
de Jong, Paul E.;
Gansevoort, Ron T.

Publication type:

Article

Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes.

Published in:

Diabetes Care, 2011, v. 34, n. 4, p. 975, doi. 10.2337/dc10-1545

By:

NAUTA, FERDAU L.;
BOERTIEN, WENDY E.;
BAKKER, STEPHAN J. L.;
VAN GOOR, HARRY;
VAN OEVEREN, WIM;
DE JONG, PAUL E.;
BILO, HENK;
GANSEVOORT, RON T.

Publication type:

Article

Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism.

Published in:

American Journal of Nephrology, 2020, v. 51, n. 11, p. 861, doi. 10.1159/000511000

By:

Heida, Judith E.;
Minović, Isidor;
van Faassen, Martijn;
Kema, Ido P.;
Boertien, Wendy E.;
Bakker, Stephan J.L.;
van Beek, André P.;
Gansevoort, Ron T.

Publication type:

Article

Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?

Published in:

American Journal of Nephrology, 2015, v. 41, n. 3, p. 248, doi. 10.1159/000382081

By:

Casteleijn, Niek F.;
Zittema, Debbie;
Bakker, Stephan J.L.;
Boertien, Wendy E.;
Gaillard, Carlo a.;
Meijer, Esther;
Spithoven, Edwin M.;
Struck, Joachim;
Gansevoort, Ron T.

Publication type:

Article

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.

Published in:

Kidney International, 2013, v. 84, n. 6, p. 1278, doi. 10.1038/ki.2013.285

By:

Boertien, Wendy E;
Meijer, Esther;
de Jong, Paul E;
Bakker, Stephan J L;
Czerwiec, Frank S;
Struck, Joachim;
Oberdhan, Dorothee;
Shoaf, Susan E;
Krasa, Holly B;
Gansevoort, Ron T

Publication type:

Article

Urinary biomarkers in autosomal dominant polycystic kidney disease: is there no prognostic value?

Published in:

Kidney International, 2012, v. 82, n. 3, p. 361, doi. 10.1038/ki.2012.146

By:

Boertien, Wendy E;
Meijer, Esther;
Gansevoort, Ron T

Publication type:

Article